TipRanks
Go Ultimate55% OFF

Easton Pharmaceuticals (EAPH) Financial Statements

Easton Pharmaceuticals Financial Overview

Easton Pharmaceuticals's market cap is currently $1.34K. The company's EPS TTM is $-0.00; its P/E ratio is -0.20; Easton Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 20Dec 19Dec 18
Income Statement
Total Revenue$ 0.00$ 1.56M$ 378.59K
Gross Profit$ 0.00$ 201.40K$ 106.91K
Operating Income$ -189.00K$ -322.00K$ -124.00K
EBITDA$ -8.33K$ -6.59K$ -4.94K
Net Income$ -189.00K$ -323.00K$ -169.00K
Balance Sheet
Cash & Short-Term Investments$ 23.19B$ 247.97K$ 66.30K
Total Assets$ 10.19M$ 17.17M$ 10.15M
Total Debt$ 2.48M$ 8.46M$ 2.18M
Net Debt$ 2.48M$ 8.21M$ 2.11M
Total Liabilities$ 3.28M$ 10.08M$ 3.01M
Stockholders' Equity$ 6.91M$ 7.10M$ 7.14M
Cash Flow
Free Cash Flow$ -207.34K$ 491.88K$ -6.86K
Operating Cash Flow$ -188.54K$ 510.68K$ -6.86K
Investing Cash Flow$ -18.80K$ -18.80K$ 0.00
Financing Cash Flow$ 64.00$ 1.12K$ 18.37K

Currency in USD

Easton Pharmaceuticals Earnings and Revenue History

-1M01M2M-48 %-36 %-24 %-12 %EarningsProfit Margin201820192020RevenueEarningsProfit Margin

Easton Pharmaceuticals Debt to Assets

08M16M24M20 %40 %60 %80 %LiabilitiesDebt to Assets201820192020AssetsLiabilitiesDebt to Assets

Easton Pharmaceuticals Cash Flow

-400K-200K0200K400K600K201820192020OperatingInvestingFinancing

Easton Pharmaceuticals Forecast EPS vs Actual EPS

0Q1 19EPS EstimateBeatMiss